Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method

Diagnostic Cytopathology

Volumn 32, Issue 2, 2005, Pages 82-87

  Moore, Grace D ^a   Lear, Sheron C ^a   Wills Frank, Lisa A ^a   Martin, Alvin W ^a   Snyder, James W ^a   Helm, C William ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical dysplasia; Cyclin E; p16; p21cip1; p27kip1; ThinPrep

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; PEROXIDASE; PROTEIN P16;

ARTICLE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE PREPARATION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 12744259899     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20186     Document Type: Article

References (24)

1. Parkin DM, P Pisani, J Ferlay. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-1392.
3. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-1400.
4. Nygard JF, Sauer T, Skjeldestad FE, Skare GB. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program. Acta Cytolog. 2003;47:991-1000.
5. Muñoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
6. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-698.
7. Hausen ZH. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Nat Cancer Inst 2000;92:690-698.
8. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
9. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-1748.
10. Steeg PS, Abrams JS. Cancer prognostics: past, present, and p27. Nat Med 1997;3:152-54.
11. Troncone G, Vetrani A, de Rosa G, Gerbasio D, Palombini L. Cyclin dependent kinase inhibitor p27Kip1 expression in normal and neoplastic cervical epithelium. J Clin Pathol 1999;52:880-887.
12. Dellas A, Schultheiss E, Leivas MR, Moch H, Torhorst J. Association of p27Kip1, cyclin E, and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res 1998;18:3991-3998.
13. Schmidt-Grimminger DC, Wu X, Jian Y, Broker TR, Chow LT. Posttranscriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities. Am J Pathol 1998;152:1015-1024.
14. Cho NH, Kim YT, Kim JW. Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors. Yonsei Med J 2002;43:722-728 (review).
15. Caldeira S, de Villiers EM, Tommasino M. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein. Oncogene 2000;19:821-826.
16. Weaver EJ, Kovatich AJ, Bibbo M. Cyclin E expression and early cervical neoplasia in ThinPrep specimens. A feasibility study. Acta Cytolog 2000;44:301-304.
17. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003;56:56-63.
18. Shiozawa T, Shiohara S, Kanai M, Konishi I, Fujii S, Nikaido T. Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1). Cancer 2001;92:3005-3011.
19. Van de Putte G, Holm R, Lie AK, Trope CG, Kristensen GB. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 2003;89:140-147.
20. Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Exp Cell Res 2001;265:152-166.
21. Sugimoto M, Martin N, Wilks DP, et al. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Oncogene 2002;21:8067-8074.
22. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 1996;13:2323-2330.
23. Zehbe I, Ratsch A, Alunni-Fabbroni M, et al. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions. Oncogene 1999;18:2201-2211.
24. The 2001 Bethesda System. JAMA 2002;287:2114-2110.